Risk of Cardiovascular Disease Elevated for Certain Patients with Systemic Lupus Erythematosus

In this research presented at ACR 2023, a connection between antiphospholipid antibodies and a greater potential risk of cardiovascular disease was identified.

Related Keywords

China ,California ,United States ,Yufang ,Jiangxi ,Peking ,Beijing ,San Diego ,Chinese ,Mengtao Li ,Jiuliang Zhao ,Chinese National Key Research Rd Program ,American College Of Rheumatology ,Research Group ,Union Medical College Hospital ,American College ,Peking Union Medical College Hospital ,East Asian ,Antiphospholipid Antibodies ,Systemic Lupus Erythematosus ,Accessed November ,Systemic Lupus ,Racr ,Aisle ,Lupus ,Cardiovascular Disease ,